Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Experimental Physiology
|
May 7, 2013
The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease
Paul D Upton, Nicholas W Morrell
Current Opinion in Pharmacology
|
March 27, 2009
TGF-beta and BMPR-II pharmacology--implications for pulmonary vascular diseases
Paul D Upton, Nicholas W Morrell
Biochemical Society Transactions
|
May 27, 2015
Connexin-mediated regulation of the pulmonary vasculature
Yvonne Dempsie, Patricia Martin, Paul D Upton
Biochemical Society Transactions
|
November 23, 2011
Angiogenesis regulation by TGFβ signalling: clues from an inherited vascular disease
Marwa Mahmoud, Paul D Upton, Helen M Arthur
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
April 18, 2022
An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension
Paul D Upton, Benjamin J Dunmore, Wei Li, et al.
Circulation Research
|
April 26, 2019
Letter by Morrell et al Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension"
Nicholas W Morrell, Paul D Upton, Wei Li, et al.
Molecular Pharmacology
|
November 9, 2007
Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells
Paul D Upton, Lu Long, Richard C Trembath, et al.
Global Cardiology Science & Practice
|
January 19, 2016
The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension
Mark L Ormiston, Paul D Upton, Wei Li, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 14, 2013
Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3
Paul D Upton, Rachel J Davies, Tamara Tajsic, et al.
The Journal of Biological Chemistry
|
April 16, 2009
Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells
Paul D Upton, Rachel J Davies, Richard C Trembath, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Experimental Physiology
|
May 7, 2013
The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease
Paul D Upton, Nicholas W Morrell
Current Opinion in Pharmacology
|
March 27, 2009
TGF-beta and BMPR-II pharmacology--implications for pulmonary vascular diseases
Paul D Upton, Nicholas W Morrell
Biochemical Society Transactions
|
May 27, 2015
Connexin-mediated regulation of the pulmonary vasculature
Yvonne Dempsie, Patricia Martin, Paul D Upton
Biochemical Society Transactions
|
November 23, 2011
Angiogenesis regulation by TGFβ signalling: clues from an inherited vascular disease
Marwa Mahmoud, Paul D Upton, Helen M Arthur
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
April 18, 2022
An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension
Paul D Upton, Benjamin J Dunmore, Wei Li, et al.
Circulation Research
|
April 26, 2019
Letter by Morrell et al Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension"
Nicholas W Morrell, Paul D Upton, Wei Li, et al.
Molecular Pharmacology
|
November 9, 2007
Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells
Paul D Upton, Lu Long, Richard C Trembath, et al.
Global Cardiology Science & Practice
|
January 19, 2016
The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension
Mark L Ormiston, Paul D Upton, Wei Li, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 14, 2013
Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3
Paul D Upton, Rachel J Davies, Tamara Tajsic, et al.
The Journal of Biological Chemistry
|
April 16, 2009
Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells
Paul D Upton, Rachel J Davies, Richard C Trembath, et al.
Page
of 7